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Abstract
Background: Enhancing the use of evidence in policymaking is critical to addressing the global burden of
nutrition-related disease. Whilst the public health nutrition community has embraced evidence-informed
policymaking, their approach of defining relevant evidence and evaluating policy has not brought about major
shifts in policymaking. This article uses a public health nutrition case study to refine a novel theory-informed
framework for enhancing the use of evidence in government public health nutrition policymaking. Our aim is to
contribute insights from evidence-informed policy to the emerging paradigm in public health nutrition
policymaking.
Methods: An enquiry framework informed by three groups of theories underpinning evidence-informed policy was
used to explore the role of socially mediated processes on the use of evidence. A public health nutrition case study
on food marketing to New Zealand children was conducted to refine the framework. Interview data collected from
54 individuals representing four key policy stakeholder groups, policymakers, academics, and food industry and
non-government organisations were analysed using deductive and inductive thematic analysis. To enhance
theoretical robustness, an alternative hypothesis of political explanations for evidence use was explored alongside
the enquiry framework.
Results: We found the prevailing political climate influenced the impact of advocacy for evidence inclusive
processes at the meta-policy and policymaking process levels and in policy community relationships. Low levels of
awareness of the impact of these processes on evidence use and uncoordinated advocacy resulted in the
perpetuation of ad hoc policymaking. These findings informed refinements to the enquiry framework.
Conclusion: Our study highlights the role advocates can play in shifting government public health nutrition
policymaking systems towards enhanced use of evidence. Our Advocacy for Evidence Use framework argues for a
three-channel approach to advocacy for using evidence in the public interest. The framework provides a means for
building a constituency for evidence use in public health nutrition and adds understanding about advocacy to the
field of evidence-informed policy. Future research should examine the impact of coordinated advocacy on public
health nutrition policymaking systems.
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Background
Dietary risk factors are now the leading contributors to
the global burden of disease [1]. In particular, subopti-
mal nutrition is driving many aspects of global patterns
of disease. As rates of overweight and obesity continue
to increase unevenly around the world, attention is turn-
ing to government systems for the development of re-
medial policies [2]. Patterns in New Zealand reflect
these trends, with 31% of adults being obese and Maori
and Pacific adults having higher rates of obesity, of 47%
and 66%, respectively [3]. For decades, leading nutrition-
ists have been calling for a new paradigm in nutrition
policymaking where evidence from a variety of sources
is systematically considered [4–6]. The 2015 Lancet
series on obesity argues for ‘new thinking’ by addressing
issues at both the individual and environmental level
and pursuing policy-based approaches to changing the
food environment [7–10]. However, for these science-
based arguments to gain traction this evidence-policy
interface requires closer examination [11]. We define
evidence broadly including quantitative, qualitative and
synthesised evidence produced by a range of methods.
Government policymakers are confronted with a num-
ber of challenges in protecting and promoting public
health nutrition (PHN). The problems for which they
need to formulate policy are often complex, substantial
and contested. Although evidence-informed policy-
making is promoted as the ideal, it rarely takes place as
a rational and linear process. Instead, advocacy has a sig-
nificant influence on how and why the decision making
process plays out [12, 13]. Here, we define advocacy as
working proactively to change upstream environmental
factors, in particular the policies, regulations and institu-
tional practices which influence the personal health
choices of large population groups [14]. Effective policy
advocacy involves a range of interpersonal and organisa-
tional level strategies orchestrated by skilled individuals
whose primary activities are building advocacy coalitions
and engaging with decision makers in a bottom up man-
ner [15]. In this regard, as we have argued elsewhere
[16], there are three areas where advocacy can explain
when evidence is used in the policymaking process.
Advocacy by influential policy actors with the aim of
increasing evidence use has not been systematically ex-
amined beyond three lines of enquiry: Nutley et al.’s [17]
application of diffusion of innovation frameworks to the
idea of evidence use; Sabatier et al.’s [18] Advocacy Co-
alition Framework; and Greenhalgh et al.’s [19] system-
atic review of diffusion of innovation in health service
organisations. The aim of this article is to use empirical
and theory-informed conceptual thinking to build a
framework for using a variety of evidence in PHN pol-
icymaking. Our earlier framework on the role of advo-
cates in evidence-informed policymaking [16] is tested
and refined in a PHN policy case study in the New Zea-
land environment. PHN policymaking in New Zealand
provides a rich case for a study on advocacy for evidence
use. It is a discrete policy area with a number of high
stakes policy issues with scientific evidence bases and
clearly identifiable actors, yet from 2008 to 2014, the
Government had a position of minimal action. The re-
vised advocacy framework provides additional features
to the Institute of Medicine, World Obesity, and WHO
models for advancing evidence use in PHN policymaking
[20–22].
Enquiry framework
The Role of Advocates for Using Evidence framework ar-
gues that advocates are able to shift (1) meta-policy ar-
rangements, (2) PHN policy community relationships,
and (3) policymaking processes to enhance the use of
evidence [16]. These three aspects of PHN policymaking
amenable to advocacy emerged from our mining of the-
oretical frameworks addressing the types of evidence
used in public health policymaking, the influence of
power and interests on evidence use, and social aspects
of policy processes. We focused on identifying socially
mediated policymaking structures and processes that
exert considerable influence on how, when and why evi-
dence is used. The enquiry framework portrays these
three mutually reinforcing aspects as policymaking com-
ponents harnessing the wider context of policy-relevant
knowledge to produce evidence-informed policy.
Meta-policy
Meta-policy, the highly influential written and unwritten
rules about policymaking, effectively determine the use
of evidence in policy processes. These ‘rules’ govern who
is included and excluded, time frames for decision mak-
ing and the extent and status of external input [23, 24].
Drawing on a social interaction theory, diffusion of
innovation, this component proposes that opinion leader
advocates’ role is to work through existing PHN advo-
cacy coalitions to direct advocacy towards meta-policy
level influences on evidence use [25].
Sustained relationships
This component proposes that sustained relationships
between broadly based members of a policy community
enable effective advocacy for evidence use. Here, the role
of skilled individuals is to unite networks across PHN
policy communities and across policy issues by diffusing
the novel ‘idea’ that enduring relationships are critical
for effective advocacy. Advocacy is for policy processes
that promote the public interest through consideration
of broadly based evidence.
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Deliberative processes
Building on Flitcroft’s argument that deliberative policy-
making processes have the potential to reframe policy
dilemmas and resolve policy controversies, this compo-
nent proposes that the role of advocates is to pursue in-
clusive structures and systematic processes [24]. Their
goal is Lomas et al.’s [26] well known deliberative policy-
making process model, particularly consultation with all
parties affected by an outcome, inclusion of a fair repre-
sentation of scientists and other stakeholders, high-
quality syntheses of the scientific evidence and skilful
chairing.
Methods
Case study design
This study sought to produce a robust explanatory
framework through a real world policy case study. A de-
ductive approach was used to refine an existing concep-
tual framework developed from a synthesis of literature
relevant to evidence-informed policy. Policy case study
interview data explored PHN policy actors’ views on the
ability of the framework to explain advocacy for using
evidence. Concurrently, a grounded theory approach was
used to explore emerging explanatory themes. A rival hy-
pothesis, political explanations for evidence use, was ex-
plored using the same approach. Food marketing to New
Zealand children was chosen as an exemplary single case
study. This policy area provided rich case study data as a
well-established evidence base existed, a range of identifi-
able policy actors were involved, there was controversial
meta-policy and the New Zealand Government had a clear
policy position, see Additional file 1 Case Study back-
ground. The University of Otago Human Ethics Committee
granted ethical approval for the qualitative interviews.
Data collection
In-depth conversational interviews explored the role of
advocates for using evidence in PHN policy on food
marketing to children. Members of the New Zealand
PHN policy community with an interest in food market-
ing to children were relatively easily identifiable by the
snowballing method. The first interviewees were identi-
fied through having a senior position in an organisation
affected by food marketing to children policy and by be-
ing known for having or being able to influence policy
processes. Individuals without organisational affiliations
or with no profile on food marketing to children policy
were excluded. Over 9 consecutive weeks (July–August
2012), 54 in-depth conversational interviews, lasting 30–
40 minutes, were conducted either by telephone or face-
to-face. Four distinct groups emerged within this policy
community: policymakers, the political and bureaucratic
decision-makers; policy active academics, the sources of
scientific evidence; PHN non-governmental organisation
(NGO) groups, the organised civil society groups with
interests in policy and evidence; and the food industry,
the companies and coalitions with a high stakes involve-
ment in policy processes. All interviewees were asked
open-ended questions on their experiences of advocacy
for evidence use. Questions were structured around the
three components of the enquiry framework and how
politics influenced the use of evidence. Additional file 2
contains the interview guide.
The interview sample comprised 16 policymakers, 13
middle to senior level food industry employees, 13 man-
agers in non-government organisations, and 12
research-active academics interested in policy. As far as
possible, interviews were conducted in blocks by cat-
egory group. Interviews were transcribed within a short
time frame of the interview using voice recognition soft-
ware.1 To ensure the sample size was large enough to
produce sufficient rich and comprehensive data for the
intended analyses, interviews within each category were
continued until convincing redundancy of information,
i.e. data saturation, had been achieved.
Data analysis
Respondents were assigned a group identifier to identify
congruent and divergent views by group: policymakers,
academics, NGOs, and food industry. Group member-
ship appeared stable at the time of the interviews, with
no interviewee purporting to be a member of more than
one group. To ensure anonymity, interviewees were
assigned a unique code and number, e.g. PM 1, was an
individual policymaker.
Thematic analysis was performed on the fully tran-
scribed interview data using the four category themes
generated by the enquiry framework: meta-policy, sus-
tained relationships, deliberative processes and the alter-
native explanation, political influences. Initial coding
allocated comments as supporting or disagreeing with
the enquiry framework components or the alternative
explanation, or as a potential emerging theme. There were
iterative rounds of data review to confirm the allocation of
text comments to a code. Subthemes developed based on
frequency of coded responses and were merged following
a critical review of code allocation and examination of
common conceptual links. Major category theme and sub-
theme descriptions were then refined. PF undertook the
initial coding. This was checked by RG and ML.
Results
The results are organised around the role of advocates
in the three components of the enquiry framework:
meta-policy, sustained relationships and deliberative pol-
icy processes. The role of politics is also explored as an
alternative explanation. Whilst food marketing to chil-
dren was the entry point for the interviews, it was
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apparent early in each interview that issues in the wider
PHN policy environment explained the current situation
on food marketing to children. Consequently, data was
obtained on both food marketing to children and
broader PHN issues.
Meta-policy
In New Zealand, institutions inside and outside govern-
ment have a government mandate to develop and imple-
ment nutrition-related policy. The key institutions are
two government departments, the Ministry of Health
(MoH) and the Ministry for Primary Industries, MoH
Public-Private Partnerships (PPPs) with a major NGO
and with the Food Industry, and the non-regulated
industry-led Advertising Standards Authority.
In government-funded organisations, formal meta-
policy structures and processes exerted a major influ-
ence on the impact of any advocacy for using evidence.
For the MoH, the dis-establishment in 2009 of their Nu-
trition Advisory Committee represented a significant
structural barrier to further evidence-informed policy
development. Many aspects of PHN policy advocacy
were affected by the removal of this key committee
known for rigorous consideration of scientific evidence.
The Nutrition Advisory Committee was not alone, as
the centre right Government in their first term of office
(elected in 2008) disbanded a number of expert advisory
committees. A senior policymaker observed:
“…because at the time the ministry had a vast number
of advisory committees for just about any everything, it
was questionable how much value they added.”
Policymaker 6
The same Minister’s (2008–2014) well-known hands-
on approach and aversion to discussing public health is-
sues became a barrier to advocacy for creating alterna-
tive structures for providing evidence-informed policy
advice. Formal channels for science-based evidence-
informed policy advice were further compromised by an
internal restructuring of government departments,
where technical nutrition experts were replaced by polit-
ically pliable non-specialist policy analysts.
These meta-policy changes, while not impacting on
the type of evidence most groups were advocating, did
impact on channels used by academics and smaller
NGOs. The food industry and larger NGOs continued to
use their own well-oiled direct advocacy channels. With
the loss of their only structural channel for scientific evi-
dence to reach policymakers, smaller NGOs and aca-
demics increased their use of ad hoc informal processes.
Larger NGOs continued proactive advocacy directly to
policymakers for their more broadly based scientific and
contextual evidence to be considered. Similarly, the food
industry continued to use direct advocacy, although with
an increased emphasis on scientific evidence alongside
their market-based data.
Members of the food industry were also proactive with
informal advocacy to shift meta-policy towards arrange-
ments where industry had a larger role in policy devel-
opment. Most academics and smaller NGOs were more
reactive responding to issues as they arose, with little if
any awareness of the influence of meta-policy. As newer
collaborative meta-policy arrangements, PPPs were in-
creasingly common across government and bureaucrats
believed they had political support to develop partner-
ships with the food industry. However, the only NGO
working in a MoH-funded PPP perceived a power imbal-
ance that compromised their independence.
The role of civil society groups as the ‘voice of evi-
dence’ in formal and informal policy discussions
emerged as an important issue for NGO and academic
interviewees. In the prevailing political climate, civil so-
ciety voices were seen as having more influence than sci-
entific experts, particularly when a constituency was
built for public health action. Some NGOs deliberately
engaged in ‘sideways advocacy’ by packaging scientific
evidence to enable community group voices to speak the
evidence.
Sustained relationships
As informal policy processes dominated nutrition policy-
making, most social interactions across the policy com-
munity were based on informal relationships. Despite
only a few formal committees facilitating relationships
between sectors, informal mutually beneficial relation-
ships flourished. The relationship patterns captured
below (Fig. 1) portray how differing levels of mutuality
influenced levels of interaction between key groups.
Advocacy for formal ongoing relationships between
major groups in the policy community was distinctly
limited. Formal relationships existed only where struc-
tures enabled relationships between individuals from dif-
ferent sectors. Only the two major nutrition NGOs had
academics as long-standing members of advisory com-
mittees. These relationships were considered to have
high levels of mutuality. One business industry NGO
also maintained a number of advisory groups with a
broad membership, and a notable absence of academics.
Senior health bureaucrats reported enjoying long-
standing, informal relationships with senior academics
where either party would telephone the other for advice
or an alternative perspective on an issue. These relation-
ships often began as formal relationships and became
sustained by mutuality arising from trust, respect and
exchange of information. Most Members of Parliament
(MPs) also had their own informal relationships with
trusted academics. However, these relationships were
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short lived compared to bureaucrats’ relationships. More
politically attuned NGOs also initiated and maintained
relationships with elected MPs and senior bureaucrats.
For the food industry, initiating and maintaining infor-
mal relationships with politicians and bureaucrats was a
priority activity. Food industry members frequently coor-
dinated their engagement with government through rep-
resentative groups, including a powerful coalition, the
Food Industry Group, established in 2003. In compari-
son, nutrition NGOs could not sustain coordinated ad-
vocacy. Competition between academics based on
University affiliations combined with the disjointed
NGO sector created difficulties for bureaucrats seeking
external public health input on policy issues. A senior
bureaucrat commented:
“Who is public health, is it the Public Health
Association, or is it some key academics, who is it?…
Industry is easier because there are key bodies.”
Policymaker 3
Deliberative policy process
Deliberative policymaking processes were virtually non-
existent, as most policy processes used selected evidence
in selected ways. For many bureaucrats, political inter-
ference and the lack of systematic internal processes for
reviewing public health evidence meant they were only
involved in advising on the efficacy of implementation
options and had no opportunity to advocate for alterna-
tive processes.
Several major food companies initiated a type of delib-
erative policy process in providing scientific and other
evidence directly to policymakers, believing this added
credibility to industry submissions and interactions with
MPs. One food industry representative understood their
material provided bureaucrats with evidence that was
not available from other sources:
“They would take all the science they could get, they
know we have the science at our fingertips and will
ask for it, not just science but evidence in general, sales
figures.” Food industry member 4
NGOs, on the other hand, provided scientific evidence
to government through formal structures, committees
and consultation rounds. Experienced advocates in all
groups were keenly aware that their scientific evidence-
based advocacy had minimal impact compared to other
policy inputs.
As most NGOs were dependent on government fund-
ing they pursued a politically pragmatic and conservative
approach to PHN advocacy. Senior NGO interviewees
attributed the high level of political involvement in PHN
policy processes to New Zealand’s Mixed Member Pro-
portional electoral system. A succession of coalition gov-
ernments with small majorities over the last decade had
forced MPs to be responsive to their electorates and
party ideology. A NGO representative believed this polit-
ical fragility enhanced the influence of civil society
groups.
Advocacy by some policy active academics was hin-
dered by fear of being ‘labelled’ by politicians and bu-
reaucrats when their views differed from Government
ideology. These academics believed politicians and se-
nior bureaucrats’ perceptions of their personal political
views determined whether their advice was sought. Some
expressed concern around the impact of being labelled
on future competitive government research funding
applications.
Discussion
A complex relationship between evidence and policy-
making was evident in this investigation of advocates’
role in three channels that influence evidence use in
PHN policymaking. Much of this complexity arose from
interdependencies between the channels working to fa-
cilitate or hinder the use of evidence.
Gibson’s argument for the role meta-policy plays in
evidence use highlights the need for evidence use advo-
cates to be aware of meta-policy [23]. Our results
Fig. 1 Mutuality in linkages between major players in the New Zealand public health nutrition community.
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indicate a low-level of awareness of formal and informal
meta-policy helps explain the limited advocacy for en-
hanced use of evidence. Head recognises the need for
political incentives to promote organisational climates
and cultures supportive of evidence-informed decision-
making processes [27]. However, it appears that similar
incentives are needed at the meta-policy level to shift or-
ganisations towards evidence-informed policymaking. In
this study, the lack of powerful political incentives for al-
ternative meta-policy may be attributed to three coincid-
ing factors. A weak policy community being largely
unaware of meta-policy, a hands on Minister of Health
and influential senior bureaucrats maintaining the status
quo by continually framing advice to be acceptable to
their Ministers.
A major consequence of low profile meta-policy is an
absence of transparency. When industry groups advocate
for a change in meta-policy arrangements this is seen by
groups with public health values as an exercise of asym-
metrical power by another group with conflicting values.
In the field of evidence-informed policy, the principle of
transparency is frequently applied to high quality, ac-
cessible evidence and policy processes yet rarely to
meta-policy guiding how evidence is used [27–29]. This
relationship between low profile and transparency cre-
ates problems for the wider policy community as it pre-
vents consideration of the harm and benefit
consequences of the meta-policy level ‘rules’ for using
evidence.
In relation to the second channel, that of sustained re-
lationships, the findings extend the work of Flitcroft
et al. [24], Hanney and Gonzalez-Block [30], and Lavis
et al. [31], who promote the role of organisational struc-
tures in supporting dialogue on specific policy issues.
Our work indicates that, when these structures exist
over time and across policy issues, they are important
for sustaining relationships across a policy community.
For public health groups an influential government-led
committee was pivotal for sustaining relationships when
it existed, whereas for food industry members their ad-
vocacy coalition was a uniting structure.
Along with transient formal structures, the pattern of
long-standing networks across the policy community
can help explain uncoordinated and conflicting advocacy
activities. In the case study, food industry groups exhib-
ited Sabatier’s characteristics of advocacy coalitions [18].
Groups were united by high-level interests around reten-
tion of industry self-regulation, which in turn directed
advocacy activities and ultimately determined the lon-
gevity of a key coalition.
In contrast, NGO and academic groups failed to co-
ordinate their activities. These groups functioned as
small clusters of tightly linked individuals, more typical
of social networks who do not have collective policy
goals [32]. Organised advocacy was constrained by lim-
ited resources relative to larger well-resourced food in-
dustry groups. Relationships between individuals were
strong, being sustained over long periods of time and
across policy issues by mutual trust and resource de-
pendence around the exchange of knowledge. However,
NGO and academic coalitions could not be sustained
since members disagreed on middle-level values around
priorities for nutrition policy. Interestingly, these dis-
agreements overrode agreement on high-level beliefs
around the primacy of scientific evidence and the crucial
role of nutrition in promoting health.
Sabatier argues that beliefs at all levels influence how
coalition members respond to new information [18].
Our analysis suggests medium-level beliefs influence the
establishment and longevity of advocacy coalitions. Be-
cause belief disagreements occurred in weak policy com-
munity groups, together, these two social influence
factors explain the un-coordinated advocacy. For evi-
dence use advocacy, this analysis highlights the need to
align both medium and high-level beliefs of policy com-
munity subgroups.
Interestingly, although most members of outside gov-
ernment advisory committees fulfil Rogers’ criteria for
opinion leaders they did not attempt to influence wider
policymaking systems [25]. This indicates a second area
where low levels of awareness hinder advocacy.
Cognizance of how on-going relationships facilitate the
conceptual use of evidence is needed to address so-
called ‘wicked problems’ [33] in PHN policy, where
causes and solutions are highly contested. In Rogers’ dif-
fusion of innovation model, persuading opinion leaders
of the relative advantage of an innovation is the first step
in the adoption of new ideas. This suggests that persuad-
ing opinion leaders of the merits of establishing struc-
tures that support on-going relationships is a priority
issue for the policy community.
In examining deliberative processes, the third channel,
two government actions undermined policymakers’ abil-
ity to systematically use broadly based evidence. Dises-
tablishing the Nutrition Advisory Committee and side-
lining MoH technical nutrition experts prepared the
ground for more politically driven policymaking pro-
cesses. The resulting reduction in structural capacity for
addressing complex issues through on-going conversa-
tions between evidence producers and users helps ex-
plain the rise in ad hoc policy development [34].
Compared to Lomas’ model for deliberative policy-
making where skilled, transparent synthesis of evidence
includes stakeholders’ values, informal politically driven
processes appeared to permit only highly selected evi-
dence to inform policy development [26]. In the absence
of skilfully chaired deliberations by balanced stakeholder
groups including scientists the outcome could be
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considered ‘ill-informed’ policy, in comparison to Lavis
et al.’s [35] construct of ‘well-informed’ policy.
Furthermore, without formal government-led policy-
making structures and processes or rules for engage-
ment, food industry groups have a rationale for building
relationships with senior bureaucrats and politicians. As
policymakers’ source of readily accessible ‘scientific ad-
vice’, industry representatives exert considerable influ-
ence over policy processes. Although the food industry
meet Lomas’ criteria of a stakeholder affected by the out-
come of a policy decision, their role in collaborative pro-
cesses is not explicitly addressed in the deliberative
processes literature [26]. This highlights a limitation of
existing models for deliberative health policy processes:
the unstated assumption that all groups involved share a
public good interest in promoting health.
Politics – alternative hypothesis
Diverse explanations exist for the political influences on
what, how, when and where evidence is used in policy
processes. These range from the exercise of structural
power and the influence of policymaking systems
through to changing models of governance. The political
nature of PHN policymaking has been attributed to
competition between the values, beliefs and power bases
of diverse stakeholders [6, 13, 36, 37]. Political explana-
tions for evidence use suggest that the way an issue is
framed influences what counts as evidence and how it is
managed by the political system [27, 38].
In framing obesity as an individual issue, structurally
powerful industry groups aligned their position with pre-
vailing political ideology. Jenkin et al. [39] argues this
policy frame has determined what counts as policy-
relevant evidence and explains the New Zealand Gov-
ernment’s inaction on PHN policy.
In addition, three policy systems level factors offer fur-
ther political explanations for the role of advocates in in-
fluencing the use of evidence. Firstly, although New
Zealand civil society groups are politically influential,
their low profile on PHN issues prevented community
groups from being a voice for evidence. Secondly, the
lack of coordinated advocacy between NGO and aca-
demic members of the PHN community is partly attrib-
utable to internal politics. While this situation may arise
from local conditions, Gibson observes similar patterns
across the health sector. As health evidence is complex,
rational evaluations are only possible when values are
considered concurrently [23]. As PHN policymaking
processes prevented values and evidence being consid-
ered transparently, differences between these groups
were exacerbated. Thirdly, the Government’s practice of
‘branding’ individuals and dismissing senior expert advi-
sors whose views did not align with their ideology gener-
ated wariness among most academics about engaging in
political advocacy. This finding supports Lin’s view of re-
searchers and policymakers operating in competing ra-
tionalities, which do not predispose either group to
engage easily with the other [40]. Together, these
system-level factors created a situation where the wider
public health community exerted no political pressure
on policymaking systems.
Emerging shifts in PHN governance add another layer
of complexity to the systematic and transparent use of
evidence. New governance arrangements in New Zea-
land and Australia are similar to those in other sovereign
states [41–43]. Ryan’s [41] proposition that collabor-
ation, partnership and co-production underpin these ap-
proaches to public management fails to address issues of
transparency and accountability for evidence use.
Explanations for the food industry’s high level of polit-
ical influence often highlight the considerable resources
devoted to a range of relationship management activities
[44–47]. Lewis [32] draws attention to an aspect of this
influence where Australian health interest groups pro-
vide knowledge not easily available to the bureaucracy.
In this study, the food industry employed broad and tar-
geted influence strategies indicating deliberate use of
formal and informal relationships as evidence advocacy
channels.
As a heuristic device, the enquiry framework is subject
to fallibility. Theoretical understanding of how frame-
work components influenced each other over time was
difficult to assess empirically. Whilst compelling data
emerged on the political influence over PHN issues, col-
lecting interview data over a relatively short time period
created difficulty for developing a nuanced understand-
ing of how politics influences the impact of advocacy for
evidence use over time and across policy issues. A key
limitation when collecting case study data was inter-
viewees’ perceptions of evidence use. As divisions within
the policy community centred on the evidence base for
policy priorities, a number of interviewees struggled to
separate the idea of advocacy for evidence use per se,
from advocacy for consideration of their evidence.
Advocacy for evidence use (AEU) framework
Insights from the case study produced three revisions to
our ‘Role of Advocates for Using Evidence framework’
[16] incorporated into the AEU framework. First, a shift
of focus from the role of advocates to advocacy pro-
cesses and outcomes in three areas. Secondly, having
politics as the alternative hypothesis led to recognition
that political forces exert a more powerful contextual in-
fluence on advocacy than policy-relevant knowledge
which, on reflection, is an outcome of deliberative pol-
icymaking processes. Thirdly, the overall advocacy goal,
evidence-informed policymaking, moves from being an
outcome to being integral to advocacy, portrayed in the
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centre of the AEU framework (Fig. 1). This captures
how structures and systems promoting evidence-
informed policymaking are enhanced by and enhance
the impact of supportive meta-policy, sustained relation-
ships and deliberative processes.
The AEU framework and its propositions
Political theory can explain the influence of structurally
powerful groups as coalitions of interests seeking com-
mon goals. Our study suggests that another political
mechanism, advocacy, is a justifiable means for bringing
about enhanced evidence use in policymaking. As all
groups in the policy community held deep-level beliefs
about the usefulness of evidence, a new frame for policy-
making appears tenable. In this frame, the powerful
exert their influence to change meta-policy towards
structures and systems where the use of broadly based
evidence is prioritised over other policy considerations.
This proposition offers direction for the new approaches
to PHN policymaking urged by Lang and Rayner [6],
Swinburn et al. [21] and Rigby et al. [48].
The AEU framework proposes policy structure and
process change become advocacy goals for the PHN pol-
icy community. Opinion leaders across the PHN com-
munity have the capacity to use their social influence
skills to persuade members of their networks and the
government of the benefits of deliberative, transparent
use of evidence. For the ‘idea’ of using evidence to be-
come embedded in the hearts and minds of policy com-
munities, opinion leaders themselves may first need to
be persuaded of its value. Many of these influential indi-
viduals will reframe their evidence use advocacy from
calls for government to develop policies directly in-
formed by their evidence, to advocate for policy about
policymaking in the broader public interest. The AEU
framework (Fig. 2) proposes three concurrent advocacy
targets for opinion leaders:
1. New governance models where meta-policy estab-
lishes and maintains government-led structures and
processes that enable broadly based evidence to be
considered. As PHN policy issues are inextricably
linked with food industry activities, the relationship
between values and evidence requires meta-policy
rules that promote explicit and transparent pro-
cesses. The exertion of asymmetrical power is
avoided when policy processes recognise the value
base of all contributors.
2. Deliberative policy processes that acknowledge the
value of broadly based, systematically synthesised
evidence. Individuals skilled in leading iterative
processes will facilitate new collaborative approaches
to developing understanding of and solutions to
‘wicked’ policy problems. This advocacy will address
the role of government in ensuring skilled staff
undertake evidence syntheses, which incorporate the
values and interests of all contributors.
3. Establishment and maintenance of relationships
across the policy community as the basis for
effective advocacy. Opinion leaders persuaded of the
benefits of on-going trusting relationships in advo-
cacy for evidence use have the potential to assume a
key role in facilitating relationships across the policy
community. Their goal is to establish structures that
enable relationships to exist over time and across is-
sues. In addition, these leaders will be cognisant of
the need for advocacy to be based on shared high
and medium level beliefs.
The AEU framework (Fig. 2) illustrates the hypothesis
that advocacy targeted to three inter-dependent areas,
Fig. 2 Advocacy for evidence use framework.
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portrayed inside the circle, will bring about more
evidence-informed effective policymaking. Opinion
leaders engage in targeted advocacy (boxes) directed to
three goals (inside circle) using iterative, responsive
strategies (double-headed straight arrows). Wider polit-
ical forces (outside the circle) exert influence in two
ways, represented by wavy arrows capturing the less pre-
dictable influence of politics on each goal. These forces
are distinct from deliberately harnessing politically influ-
ential advocacy in three areas, conveyed by the three
straight one-way arrows between political forces and evi-
dence use advocacy. The placement of political forces in
the wider context also captures the influence of politics
over the area that will be most malleable at a point in
time. Interdependencies between each area capture the
potentially synergistic actions that may be missed by fo-
cussing on an individual area.
Conclusion
This research responded to growing pressure to better
understand the PHN evidence–policymaking interface
and strengthen PHN policymaking processes. Three
channels were identified where advocacy will shift pol-
icymaking towards enhanced use of evidence: meta-
policy, sustained relationships and deliberative policy-
making processes. The principal theoretical contribution
is adding understanding of the role of a politically medi-
ated social interaction mechanism to conceptual models
of evidence-informed policy. The AEU framework pro-
poses that targeted advocacy for evidence use will build
footbridges between decision makers and those who
generate evidence. For policymakers and the PHN policy
community the framework provides a theory-informed
rationale for advocating for deliberate connections be-
tween science, society and politics. However, it also im-
plies a central role for government in establishing
evidence use promoting structures and systems. Another
less obvious implication is the need for robust transpar-
ent systems for dialogue between all PHN actors where
the influence of values is acknowledged. Finally, the
framework provides the PHN policy community with ur-
gently needed insights on the value of building advocacy
constituencies for evidence use.
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